Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
1999-05-26
2003-09-16
Caputa, Anthony C. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C530S412000, C530S413000, C530S417000, C530S418000
Reexamination Certificate
active
06620918
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a process for separating polypeptide monomers from dimers and/or other multimers using ion-exchange chromatography.
2. Description of Background and Related Art
Attempts to purify authentic, properly folded protein from recombinant hosts have been frustrated due to the tertiary structure of the molecule. In this regard, purification of the recombinantly produced molecule often yields a heterogeneous mixture that consists largely of inactive, misfolded, insoluble, and/or soluble dimers, multimers, and disulfide-linked aggregates. Other aberrant molecules, such as fragments, nicked, oxidized, and glycosylated forms, may also be present. Thus, purification is difficult and yields of the authentic monomer are often low. See, e.g., Elliott et al,
J. Protein Chem.,
9: 95-104 (1990).
Different techniques have been used to correct these problems. For example, Chang and Swartz,
Protein Folding: in vivo and in vitro
(American Chemical Society, 1993), pp. 178-188 describe a method for solubilizing aggregated IGF-I produced in
E. coli
, using low concentrations of urea and dithiothreitol (DTT) in an alkaline buffer. U.S. Pat. No. 5,231,178 describes a method for the purification of correctly folded, monomeric IGF-I from
P. pastoris
using a combination of cation exchange, hydrophobic interaction, and gel filtration chromatography. WO 96/40776 describes a method for producing authentic properly folded IGF from yeast using a first cation exchange chromatography with the yeast cell medium, denaturing and chromatography, and performing reverse phase high performance liquid chromatography.
Separation of protein and peptide monomers from their dimers, tetramers, and multimers presents a serious challenge to the separations scientist. Size-exclusion chromatography (SEC) and Tangential-Flow Filtration (TFF) (U.S. Pat. Nos. 5,256,294 and 5,490,937) have been used for separating monomers from aggregates but have limitations. SEC can separate monomers from multimers, and in some cases monomers from dimers. The main limitations of SEC are 1) limited load volumes (typically 5% of the bed volume) requiring large columns or multiple cycles, 2) and load protein concentration (low concentration feed stocks require pre-concentration or multiple cycles on the column. Higher protein concentrations can be more viscous, thereby reducing the efficiency of the separation). Historically TFF can separate protein multimers that are ten-fold larger than the monomer. U.S. Pat. No. 5,256,294.
U.S. Pat. Nos. 4,228,154 and 5,250,663 disclose separations of albumin from mixtures. U.S. Pat. No. 4,228,154 describes use of both cation-exchange and anion-exchange chromatography steps for the purification, without separation of monomer from multimers.
There is a need for separating monomers from dimers and multimers that is satisfactory, requires the use of only one ion-exchange step, and does not have the limitations of SEC or TFF.
SUMMARY OF THE INVENTION
Accordingly, this invention provides a method for separating a polypeptide monomer from a mixture comprising dimers and/or multimers, wherein the method comprises applying the mixture to either a cation-exchange or an anion-exchange chromatography resin in a buffer, wherein if the resin is cation-exchange, the pH of the buffer is about 4-7, and wherein if the resin is anion-exchange, the pH of the buffer is about 6-9, and eluting the mixture at a gradient of about 0-1 M of an elution salt, wherein the monomer is separated from the dimers and/or multimers present in the mixture.
In this study it is demonstrated that ion-exchange chromatography—either anion or cation—is an effective means to separate protein or polypeptide monomers from their dimers and/or multimers. Separations are performed using either step or linear gradient elution. Ion exchange has several advantages over the SEC and TFF methods described above. First, separation is independent of polypeptide concentration in the load and therefore no pre-concentration is required. Second, resins can be loaded to greater than 30 mg polypeptide/mL resin and still achieve excellent separations. Third, ion-exchange resins are inexpensive and easy to use. Typical separations achieve enrichment of monomer to greater than 99.5% purity and yields in excess of 90%.
REFERENCES:
patent: 4228154 (1980-10-01), Fisher et al.
patent: 4764279 (1988-08-01), Tayot et al.
patent: 4765903 (1988-08-01), D'Andrea et al.
patent: 5110913 (1992-05-01), Coan et al.
patent: 5231178 (1993-07-01), Holtz et al.
patent: 5250663 (1993-10-01), Tenold
patent: 5256294 (1993-10-01), Van Reis
patent: 5490937 (1996-02-01), Van Reis
patent: 452753 (1991-10-01), None
patent: 460426 (1991-12-01), None
patent: 7285885 (1995-10-01), None
patent: WO 92/04970 (1992-04-01), None
patent: 96/40776 (1996-12-01), None
patent: WO 99/57134 (1999-11-01), None
Yang, J. et al. Molecular Immunology, 32(12): 873-881, 1995.*
Arndt, K.M. et al. Biochemistry 37: 12918-12926, 1998.*
Yang et al., Influence of column type and chromatographic conditions on the ion exchange chromatography of immunoglobulins. Journal of Chromatography, vol. 743, pp 171-180.*
Hahn et al., Bovine whey fractionation based on cation-exchange chromatography, Journal of Chromatography, vol. 795, pp 277-287.*
Harlow et al., “Antibody Molecules”Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory pp. 7, 10 (1988).
Roitt, “Molecules Which Recognize Antigen”Essential Immunology, Sixth edition, Blackwell Scientific Publications pp. 31, 40 (1988).
Lemque et al., “Study of the absorption of self-associating proteins on an anion exchanger:. Application to the chromatography of &bgr;-lactoglobulin B”Journal of Chromatography599:255-265 (1992).
Chaudhary, V. K., et al., “A recombinant immunotoxin consisting of two antibody variable domains fused toPseudomonas exotoxin” Nature339:394-397 (Jun. 1, 1989).
Jiskoot, W., et al., “Two-step purification of a murine monoclonal antibody intended for therapeutic application in man—Optimisation of purification conditions and scaling up”J. of Immunological Methods124:143-156 (1989).
Lynch, Paul, et al., “System for Aggregate Removal from Affinity-Purified Therapeutic-Grade Antibody”Genetic Engineering News17(19):17 (Nov. 1, 1997).
U.S. patent application Ser. No. 09/304,465, Basey et al., filed May 5, 1999.
Chang et al., “Single-Step Solubilization and Folding of IGF-1 Aggregates fromEscherichia coli”Protein Folding: In Vivo and In Vitro, American Chemical Society, Chapter 14, pp. 178-188 (1993).
Elliott et al., “Yeast-Derived Recombinant Human Insulin-Like Growth Factor I: Production, Purification and Structural Characterization”J. Protein. Chem. 9(1):95-104 (1990).
Ansaldi Deborah Ann
Lester Philip
Caputa Anthony C.
Genentech Inc.
Hasak Janet E.
Holleran Anne L.
LandOfFree
Separation of polypeptide monomers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Separation of polypeptide monomers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Separation of polypeptide monomers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3077646